|
CD 40 signalling predicts pathol complete response to neoadjuvant herceptin, T-FEC
http://breast-cancer-research.com/content/9/6/R87 from MD Anderson researchers
|
| All times are GMT -7. The time now is 07:22 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021